Literature DB >> 21868432

Brain diffuse large B-cell lymphoma in a systemic lupus erythematosus patient treated with immunosuppressive agents including mycophenolate mofetil.

B Svobodova, Z Hruskova, R Rysava, V Tesar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21868432     DOI: 10.1177/0961203311412413

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


× No keyword cloud information.
  6 in total

Review 1.  Primary central nervous system lymphoma in neuropsychiatric systemic lupus erythematosus: case-based review.

Authors:  Takanori Ichikawa; Yasuhiro Shimojima; Dai Kishida; Tomoki Kaneko; Yoshiki Sekijima
Journal:  Rheumatol Int       Date:  2020-04-06       Impact factor: 2.631

2.  Complications of immunosuppressive/immunomodulatory therapy in neurological diseases.

Authors:  Avindra Nath; Joseph R Berger
Journal:  Curr Treat Options Neurol       Date:  2012-06       Impact factor: 3.598

3.  SLE and Non-Hodgkin's Lymphoma: A Case Series and Review of the Literature.

Authors:  Prajwal Boddu; Abdul S Mohammed; Chandrahasa Annem; Winston Sequeira
Journal:  Case Rep Rheumatol       Date:  2017-03-27

4.  Eosinophilic granulomatosis with polyangiitis (EGPA) on remission with a new neuropathy: a rare case of mycophenolate induced primary CNS lymphoproliferative disease.

Authors:  Pragya Shrestha; Ian Garrahy; Shoja Rahimian
Journal:  J Community Hosp Intern Med Perspect       Date:  2020-10-29

5.  Mycophenolate Mofetil-induced Diffuse Large B-cell Lymphoma in Which a Solitary Lung Nodule Remitted Spontaneously.

Authors:  Hiroshi Kobe; Akihiro Ito; Hiroki Hayata; Keisuke Nishimura; Yasunori Ueda; Tadashi Ishida
Journal:  Intern Med       Date:  2020-08-22       Impact factor: 1.271

Review 6.  Primary breast diffuse large B-cell lymphoma in a patient with systemic lupus erythematosus: A case report and review of the literature.

Authors:  Feifei Shen; Gang Li; Huifeng Jiang; Shupeng Zhao; Fengjie Qi
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.